336191-14-1Relevant articles and documents
Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
-
, (2008/06/13)
Disclosed are certain substituted or unsubstituted pyridyl-containing spirocyclic compounds substituted with both basic and acidic functionality, which are useful in inhibiting platelet aggregation, inhibiting the binding of fibrinogen to blood platelets, and preventing or treating thrombosis
Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: Synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanes
Mehrotra, Mukund M.,Heath, Julie A.,Rose, Jack W.,Smyth, Mark S.,Seroogy, Joseph,Volkots, Deborah L.,Ruhter, Gerd,Schotten, Theo,Alaimo, Lisa,Park, Gary,Pandey, Anjali,Scarborough, Robert M.
, p. 1103 - 1107 (2007/10/03)
The synthesis and biological activity of analogues containing spiro piperidinylpyridine and pyrrolidinylpyridine templates are described. The potent activity of these compounds as platelet aggregation inhibitors demonstrates the utility of the spiro structures as central template for nonpeptide RGD mimics.